Skip to main content
Premium Trial:

Request an Annual Quote

CombiMatrix Lands $1.5M Air Force Contract

NEW YORK (GenomeWeb News) – CombiMatrix will develop microarray technology for the US Air Force Research Laboratory under a new $1.5 million contract, the company said today.

The company said it will develop automated instruments that use semiconductor microarray technology to detect chemical, biological, and environmental hazards that can affect military personnel.

The company's Homeland Security and Defense Programs Director, David Danley, said in a statement that CombiMatrix already has "developed diverse assays for identifying a variety of chemical and biological hazards using our semiconductor microarray with a small, handheld detector" for the US Department of Defense.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.